Patients diagnosed with pancreatic cancer face a poor prognosis because the tumor forms dense scar-like tissue that is difficult for chemotherapy drugs to penetrate, but a new model may help researchers develop new therapies.
A contentious debate among diabetes researchers have surrounded the regeneration of pancreatic insulin-producing cells: not if these cells regenerate, but rather how.
Researchers at Children's Hospital Colorado have identified a connection between overweight and obese teens' sleep health and their insulin sensitivity. The study used an objective measurement of circadian rhythm salivary melatonin to examine associations of sleep health with insulin sensitivity in adolescents.
Scientists have discovered the signals that determine the fate of immature cells in the pancreas. The research shows that they are very mobile and that their destiny is strongly influenced by their immediate environment.
Diabetes affects millions of people and is currently one of the most prevalent and dreaded non-communicable conditions. The condition affects around 7000 people under the age of 25 years in UK finds a new survey.
A lifelong night owl whose sleeplessness worsened as she aged, she sipped chamomile tea, popped antihistamines, and listened to relaxation tapes before bed — all to no avail. Some days she would call in sick to work, afraid she could not drive safely.
Men who use androgenic anabolic steroids—such as testosterone—may face a higher risk of early death and of experiencing more hospital admissions, according to a new Journal of Internal Medicine study.
A radioisotope used for diagnosing and treating thyroid cancer and hyperthyroidism, iodine-131 (I-131), is now being produced in the United States for the first time in almost 30 years. It is made at the University of Missouri Research Reactor (MURR) in Columbia. The center recently shipped its first batch.
Research on a new way of deploying the immune system against pancreatic cancer, an exceptionally lethal cancer that has so far resisted new immunotherapies, will receive $1 million in initial funding from Stand Up to Cancer.
The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded a total of $7 million in first-round "New Therapies Challenge" grants to seven teams of top cancer researchers to explore new pancreatic cancer treatments, the American Association for Cancer Research, the Scientific Partner of SU2C, announced today.
The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has issued a positive opinion on an orally available ghrelin agonist macimorelin (Macimorelin, Aeterna Zentaris) to be used in the diagnosis of patients with adult growth hormone deficiency.
Henry Ford Hospital researchers may have unknowingly happened on a new predictor of type 2 diabetes as part of a new ultrasound shoulder study. The predictor may be an ultrasound of the deltoid muscle, which researchers found appears much brighter on diabetic patients than on obese nondiabetic patients.